Видео ютуба по тегу Ema Orphan Designation

Orphan Drug Designation - FDA & EMA
Orphan Drug Designation - FDA & EMA
Training recording: how to submit an application for orphan medicinal product designation using IRIS
Training recording: how to submit an application for orphan medicinal product designation using IRIS
How to apply and benefit from an Orphan Drug Designation
How to apply and benefit from an Orphan Drug Designation
What are Orphan Medicines? - Video explainer
What are Orphan Medicines? - Video explainer
Definition of orphan drug by the EMA
Definition of orphan drug by the EMA
COMP Workshop Support for development of orphan medicines
COMP Workshop Support for development of orphan medicines
Orphan Drug Development | Episode 04 - How to get Orphan Drug Designation in European Union | DRA
Orphan Drug Development | Episode 04 - How to get Orphan Drug Designation in European Union | DRA
Patient Involvement - At the EMA level: evolution of Orphan Medicines
Patient Involvement - At the EMA level: evolution of Orphan Medicines
Aglatimagene besadenovec received Orphan Drug Designation from EMA for pancreatic cancer
Aglatimagene besadenovec received Orphan Drug Designation from EMA for pancreatic cancer
Orphan Drug Development | Episode 06 - USFDA vs EMA : Orphan Drug Designation | Regulatory Affairs
Orphan Drug Development | Episode 06 - USFDA vs EMA : Orphan Drug Designation | Regulatory Affairs
EU Market Access 2021- What’s in Store for Orphan Drugs and ATMPs?
EU Market Access 2021- What’s in Store for Orphan Drugs and ATMPs?
Orphan Drugs Market Challenges and EU Regulation
Orphan Drugs Market Challenges and EU Regulation
Revision of EU legislation for orphan medicines and medicines for paediatric use 17/5/2022
Revision of EU legislation for orphan medicines and medicines for paediatric use 17/5/2022
Prescient Therapeutics' PTX-100 wins EMA orphan drug status for CTCL
Prescient Therapeutics' PTX-100 wins EMA orphan drug status for CTCL
IMT Use Case: EMA support for academic medicines developers - EJP RD
IMT Use Case: EMA support for academic medicines developers - EJP RD
Breakthrough in Hepatitis D Treatment: EMA Grants Orphan Drug Designation to RBD1016
Breakthrough in Hepatitis D Treatment: EMA Grants Orphan Drug Designation to RBD1016
Module 4. EU Paediatric Regulation & Authorisation of Medicinal Products
Module 4. EU Paediatric Regulation & Authorisation of Medicinal Products
Breaking News: EMA Designates Ribo's RBD1016 as an Orphan Drug for Hepatitis Delta Treatment
Breaking News: EMA Designates Ribo's RBD1016 as an Orphan Drug for Hepatitis Delta Treatment
Information session on the pilot for expert panels' advice for orphan medical devices
Information session on the pilot for expert panels' advice for orphan medical devices
Orphan Medicines: how to sustain innovation in an area of high unmet need?
Orphan Medicines: how to sustain innovation in an area of high unmet need?